Endomaxis Surgicals Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
as on 12-12-2024
- Paid Up Capital ₹ 0.10 M
as on 12-12-2024
- Company Age 7 Year, 5 Months
- Last Filing with ROC 31 Mar 2022
- Revenue 1.47%
(FY 2020)
- Profit -15.14%
(FY 2020)
- Ebitda -8.80%
(FY 2020)
- Net Worth 61.86%
(FY 2020)
- Total Assets 26.82%
(FY 2020)
About Endomaxis Surgicals
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2022. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Kumari Deepika and Sanjeev Tiwari serve as directors at the Company.
- CIN/LLPIN
U33309DL2017PTC321214
- Company No.
321214
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
25 Jul 2017
- Date of AGM
30 Sep 2022
- Date of Balance Sheet
31 Mar 2022
- Listing Status
Unlisted
- ROC Code
Roc Delhi
Industry
Company Details
- Location
Delhi, India
- Telephone
- Email Address
- Website
- Social Media-
What products or services does Endomaxis Surgicals Private Limited offer?
Endomaxis Surgicals Private Limited offers a wide range of products and services, including Forceps & Graspers, Surgical Equipments, Endoscopy Instruments, Hospital & Medical Lights, Surgical Light Source, Laparoscopic Instruments, Scalpels, Needles & Scissors, Surgical Needles, Audio Mixer, Recorder & Transmitter, Media Receiver.
Who are the key members and board of directors at Endomaxis Surgicals?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Kumari Deepika  | Director | 25-Jul-2017 | Current |
| Sanjeev Tiwari | Director | 25-Jul-2017 | Current |
Financial Performance of Endomaxis Surgicals.
Endomaxis Surgicals Private Limited, for the financial year ended 2020, experienced modest growth in revenue, with a 1.47% increase. The company also saw a substantial fall in profitability, with a 15.14% decrease in profit. The company's net worth Soared by an impressive increase of 61.86%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Endomaxis Surgicals?
In 2020, Endomaxis Surgicals had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Alonzs Apparel Private LimitedActive 5 years 8 monthsKumari Deepika and Sanjeev Tiwari are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Endomaxis Surgicals?
Unlock and access historical data on people associated with Endomaxis Surgicals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Endomaxis Surgicals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Endomaxis Surgicals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
